BPMC
Price
$128.11
Change
-$0.04 (-0.03%)
Updated
Jun 27 closing price
Capitalization
8.27B
32 days until earnings call
CLNN
Price
$3.76
Change
-$0.16 (-4.08%)
Updated
Jun 27 closing price
Capitalization
33.95M
Interact to see
Advertisement

BPMC vs CLNN

Header iconBPMC vs CLNN Comparison
Open Charts BPMC vs CLNNBanner chart's image
Blueprint Medicines
Price$128.11
Change-$0.04 (-0.03%)
Volume$2.99M
Capitalization8.27B
Clene
Price$3.76
Change-$0.16 (-4.08%)
Volume$60.63K
Capitalization33.95M
BPMC vs CLNN Comparison Chart in %
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. CLNN commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a StrongBuy and CLNN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BPMC: $128.11 vs. CLNN: $3.78)
Brand notoriety: BPMC and CLNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 81% vs. CLNN: 57%
Market capitalization -- BPMC: $8.27B vs. CLNN: $33.95M
BPMC [@Biotechnology] is valued at $8.27B. CLNN’s [@Biotechnology] market capitalization is $33.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileCLNN’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • CLNN’s FA Score: 0 green, 5 red.
According to our system of comparison, BPMC is a better buy in the long-term than CLNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 2 TA indicator(s) are bullish while CLNN’s TA Score has 5 bullish TA indicator(s).

  • BPMC’s TA Score: 2 bullish, 6 bearish.
  • CLNN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CLNN is a better buy in the short-term than BPMC.

Price Growth

BPMC (@Biotechnology) experienced а -0.07% price change this week, while CLNN (@Biotechnology) price change was -11.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

BPMC is expected to report earnings on Jul 30, 2025.

CLNN is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($8.27B) has a higher market cap than CLNN($34M). BPMC YTD gains are higher at: 46.881 vs. CLNN (-28.814). CLNN has higher annual earnings (EBITDA): -24.01M vs. BPMC (-66.42M). BPMC has more cash in the bank: 576M vs. CLNN (9.83M). CLNN has less debt than BPMC: CLNN (20.9M) vs BPMC (467M). BPMC has higher revenues than CLNN: BPMC (562M) vs CLNN (350K).
BPMCCLNNBPMC / CLNN
Capitalization8.27B34M24,335%
EBITDA-66.42M-24.01M277%
Gain YTD46.881-28.814-163%
P/E RatioN/AN/A-
Revenue562M350K160,571%
Total Cash576M9.83M5,858%
Total Debt467M20.9M2,234%
FUNDAMENTALS RATINGS
BPMC vs CLNN: Fundamental Ratings
BPMC
CLNN
OUTLOOK RATING
1..100
7079
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
54100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3742
P/E GROWTH RATING
1..100
6596
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BPMC's Valuation (82) in the Biotechnology industry is in the same range as CLNN (85) in the null industry. This means that BPMC’s stock grew similarly to CLNN’s over the last 12 months.

BPMC's Profit vs Risk Rating (54) in the Biotechnology industry is somewhat better than the same rating for CLNN (100) in the null industry. This means that BPMC’s stock grew somewhat faster than CLNN’s over the last 12 months.

BPMC's SMR Rating (96) in the Biotechnology industry is in the same range as CLNN (100) in the null industry. This means that BPMC’s stock grew similarly to CLNN’s over the last 12 months.

BPMC's Price Growth Rating (37) in the Biotechnology industry is in the same range as CLNN (42) in the null industry. This means that BPMC’s stock grew similarly to CLNN’s over the last 12 months.

BPMC's P/E Growth Rating (65) in the Biotechnology industry is in the same range as CLNN (96) in the null industry. This means that BPMC’s stock grew similarly to CLNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCCLNN
RSI
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KZR4.440.17
+3.98%
Kezar Life Sciences Inc
PUBM11.680.24
+2.10%
PubMatic
SLAB147.85-0.78
-0.52%
Silicon Laboratories
HES138.97-1.15
-0.82%
Hess Corp
GROY2.20-0.08
-3.51%
Gold Royalty Corp

CLNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLNN has been loosely correlated with LYRA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLNN jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
-3.57%
LYRA - CLNN
38%
Loosely correlated
-30.83%
VERA - CLNN
34%
Loosely correlated
-2.71%
KZIA - CLNN
33%
Poorly correlated
-2.99%
BPMC - CLNN
31%
Poorly correlated
-0.03%
GOSS - CLNN
30%
Poorly correlated
-4.62%
More